These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37774399)

  • 1. Designer drugs.
    Pesce AJ; Krock K
    Lab Med; 2023 Nov; 54(6):553-554. PubMed ID: 37774399
    [No Abstract]   [Full Text] [Related]  

  • 2. Designer Drugs and the Impact on the Adolescent User.
    Lavelle S
    Arch Psychiatr Nurs; 2016 Jun; 30(3):447-8. PubMed ID: 27256955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deconstructing Designer Drugs.
    Sellers EM
    Clin Pharmacol Ther; 2017 Feb; 101(2):167-169. PubMed ID: 27564430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Designer drugs: Review and implications for emergency management.
    Pourmand A; Mazer-Amirshahi M; Chistov S; Li A; Park M
    Hum Exp Toxicol; 2018 Jan; 37(1):94-101. PubMed ID: 28764574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Designer drugs and anesthesia].
    Nogué S; Monsalve C
    Rev Esp Anestesiol Reanim; 2005 Apr; 52(4):191-2. PubMed ID: 15901023
    [No Abstract]   [Full Text] [Related]  

  • 6. Designer drugs. Assess & manage patients intoxicated with ecstasy, GHB or rohypnol--the three most commonly abused designer drugs.
    Goss J
    JEMS; 2001 Jun; 26(6):84-7, 90-3; quiz 94. PubMed ID: 11409205
    [No Abstract]   [Full Text] [Related]  

  • 7. Designer drugs as a cause of homicide.
    Matsumoto T; Okada T
    Addiction; 2006 Nov; 101(11):1666-7. PubMed ID: 17034448
    [No Abstract]   [Full Text] [Related]  

  • 8. When the designer label equals deadly.
    Smith M
    Emerg Med Serv; 2002 Sep; 31(9):28, 31. PubMed ID: 12398105
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-blocker and antipsychotic treatment of toxicity from so-called designer drugs.
    Richards JR; Derlet RW
    Pharmacotherapy; 2014 Aug; 34(8):e159-60. PubMed ID: 25112528
    [No Abstract]   [Full Text] [Related]  

  • 10. Nephrotoxic effects of designer drugs: synthetic is not better!
    Luciano RL; Perazella MA
    Nat Rev Nephrol; 2014 Jun; 10(6):314-24. PubMed ID: 24662435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging trends in the abuse of designer drugs and their catastrophic health effects: update on chemistry, pharmacology, toxicology and addiction potential.
    Rapaka RS; Purohit V; Schnur P; Rutter J
    Life Sci; 2014 Feb; 97(1):1. PubMed ID: 24529194
    [No Abstract]   [Full Text] [Related]  

  • 12. [Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].
    Tretter F
    Nervenarzt; 1997 Nov; 68(11):922-3. PubMed ID: 9732739
    [No Abstract]   [Full Text] [Related]  

  • 13. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME; Hampton JP
    Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designer drugs in psychiatric practice - a review of the literature and the recent situation in Hungary.
    Szily E; Bitter I
    Neuropsychopharmacol Hung; 2013 Dec; 15(4):223-31. PubMed ID: 24380963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deaths associated with new designer drug 5-IT.
    Seetohul LN; Maskell PD; De Paoli G; Pounder DJ
    BMJ; 2012 Aug; 345():e5625. PubMed ID: 22923530
    [No Abstract]   [Full Text] [Related]  

  • 16. Designer drugs--the Ecstasy and the agony.
    Kua EH
    Singapore Med J; 1997 Jan; 38(1):6. PubMed ID: 9269344
    [No Abstract]   [Full Text] [Related]  

  • 17. [Health problems of designer drugs].
    Domínguez Carmona M; Rebato AM
    An R Acad Nac Med (Madr); 2003; 120(2):209-25; discussion 225-9. PubMed ID: 14619540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Designer drugs].
    Ochoa Mangado E
    Med Clin (Barc); 2002 Sep; 119(10):375-6. PubMed ID: 12372169
    [No Abstract]   [Full Text] [Related]  

  • 19. Designer drugs in the general hospital.
    Bialer PA
    Psychiatr Clin North Am; 2002 Mar; 25(1):231-43. PubMed ID: 11912942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The family physician and designer drugs].
    Mendive JM
    Aten Primaria; 1998 Feb; 21(3):180-1. PubMed ID: 9607239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.